期刊文献+

甲状腺微小乳头状癌的形态学和免疫组织化学研究 被引量:5

Immunohistochemical and morphological characteristics of the papillary thyroid microcarcinoma
下载PDF
导出
摘要 目的:观察甲状腺微小乳头状癌的临床病理并检测其免疫表型,探讨相关疾病的鉴别诊断。方法:光学显微镜下观察223例甲状腺微小乳头状癌的组织形态;对74例甲状腺微小乳头状癌、32例甲状腺增生性病变行免疫组织化学方法标记细胞角蛋白19(CK19)、间皮细胞(MC)、细胞黏附凝集素3(Galectin-3)、CD56,复习相关文献。结果:在223例甲状腺微小乳头状癌中以滤泡状排列为主者占38.6%(86/223),核的特征不典型者占13.9%(31/223)。在74例甲状腺微小乳头状癌中CK19、MC、Galectin-3、CD56阳性表达率分别为100.0%、98.6%、98.6%、4.1%;在32例增生性病变中4者阳性表达率分别为37.5%、12.5%、18.8%、68.8%。结论:部分甲状腺微小乳头状癌细胞以滤泡状排列为主,核的特征不够典型,诊断较为困难。根据滤泡细胞增生活跃,细胞核具有乳头状癌的基本特点,病变与周围滤泡截然不同,且肿瘤性滤泡穿插于硬化间质或正常滤泡之间,可与增生性病变鉴别。CK19、Galectin-3、MC弥漫性中强阳性表达,CD56阴性表达对其诊断有重要价值,联合应用可以提高诊断的准确性和特异性。 Objctive:To investigate the immunohistochemical and morphological characteristics of the papillary thyroid microcarcinoma(PTM) ,and differential diagnosis of the related disease.Methods:The morphological characteristics of 223 patients with PTM were observed under light microscope.Seventy-four cases of PTM and 32 cases of proliferative lesion of thyroid were observed under light microscope with stains of hematoxylin and eosin and immunohistochemical staining.The antibody included CK19,MC,Galectin-3 and CD56.Results:Eighty-six cases were follicular-patterned and 31 cases nuclear features were untypical in 223 cases of PTM.The positive expression rates of CK19、MC、 Galectin-3、CD56 were 100.0%,98.6%,98.6% and 4.1% in 74 cases of PTM,and were 37.5%,12.5%,18.8%,68.8% in proliferative lesion of thyroid,respectively.Conclusion:Some cases of PTM show a follicular-patterned and the nuclear features.It is untypical compared with classical papillary thyroid carcinoma.It can be differentiated from proliferative lesion with absence of envelope,obviously various and unusually proliferated follicular cells,sclerotic stroma,neoplastic follicles among the collagen and normal follicles.The wide and intensive expression of CK19,Galectin-3,and the negative expression of CD56 are extremely useful in the diagnosis of PTM,four-marker panel with CK19,Galectin-3,MC and CD56 can improve the specificity and accuracy of the differential diagnosis of PTM.
出处 《中国现代普通外科进展》 CAS 2009年第10期842-845,849,共5页 Chinese Journal of Current Advances in General Surgery
关键词 甲状腺肿瘤 乳头状 微小癌 细胞角蛋白19 半乳凝素-3 上皮 分化抗原簇56 免疫组织化学 Thyroid neoplams·Carcinoma papillary·Microcarcinoma·Cytokeratin 19·Epithelium·Cluster differentiation 56
  • 相关文献

参考文献16

  • 1陈士超,何春年.用于甲状腺肿瘤鉴别诊断的相关分子标记物[J].临床与实验病理学杂志,2007,23(3):350-353. 被引量:11
  • 2Beesley MF,Mclren KM.Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules[J].Histopathology,2002,41(3):236-243.
  • 3Piersanti M,Ezzat S,Asa SL.Controversies in papillary microcarcinoma of the thyroid[J].Endocr Pathol,2003,14(3):183-191.
  • 4Al-Brahim N,Asa SL.Papillary thyroid carcinoma,an overview[J].Arch Pathol Lab Med,2006,130(7):1057-1062.
  • 5Baloch ZW,Abraham S,Roberts S,et al.Differential expression of cytokeratins in follicular variant of papillary carcinoma:an immunohistochemical study and its diagnostic utility[J].Hum Pathol,1999,30(10):1166-1170.
  • 6Miettinen M,Kovatich AJ,Karkkainen P.Keratin subsets in papillary and follicular thyroid lesions.A paraffin section analysis with diagnostic implications[J].Virchows Arch,1997,431(6):407-410.
  • 7Rapheal SJ,Mckeown-Eyssen G,Asa SL.High-molecular-weight cytokeratin and cytokeratin19 in the diagnosis of thyroid tumor[J].Mod Pathol,1994,7(3):295-301.
  • 8何春年,Lili H,Jin Q CH,陈士超,赵焕芬,翟金萍.甲状腺乳头状癌诊断与鉴别的可靠标记物[J].临床与实验病理学杂志,2007,23(6):694-698. 被引量:14
  • 9滕晓东,王丽君,姚洪田,李君,丁伟,严丽萍.细胞角蛋白19、galectin-3、HBME-1在甲状腺病变上的表达及鉴别诊断意义[J].中华病理学杂志,2004,33(3):212-216. 被引量:33
  • 10Schelfhout LJ,Van Muijen GN,Fleuren GJ.Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma[J].Am J Clin Pathol,1989,92(5):654-658.

二级参考文献46

  • 1杨清绪,邵春奎,冯智英,黄本强,韩安家,熊敏,赵文丽,武彤彤.CK19和甲状腺过氧化物酶表达在甲状腺疾病诊断中的作用[J].第一军医大学学报,2005,25(6):678-681. 被引量:12
  • 2郑璐滢,朱建善,王家东,许雁萍.Galectin-3、CK19和TPO表达在甲状腺良恶性肿瘤病理诊断中的价值[J].临床与实验病理学杂志,2005,21(4):449-453. 被引量:18
  • 3田桂红,马金龙,王家耀,冯建华,赵跃然,周玲.甲状腺肿瘤组织中p14^(ARF)基因纯合性缺失及其产物表达状况的研究[J].肿瘤防治杂志,2005,12(17):1292-1294. 被引量:4
  • 4王晓红,刘雨飞,鲍宇浓,崔全才,王德田.甲状腺乳头状癌RET、CK19、TG、Ki-67的表达[J].临床与实验病理学杂志,2006,22(6):692-695. 被引量:14
  • 5Kawachi K, MatsushitaY,Yonezawa S,et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol,2000,31: 428-433.
  • 6Cvejic D,Savin S, Golubovic S,et al.Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression. Histopathology, 2000, 37: 530-535.
  • 7Beesley MF, Mclaren KM. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.Histopathology,2002,41:236-243.
  • 8RenshawAA,Gould EW. Why there is the tendency to ''overdiangnose'' the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol, 2002,117:19-21.
  • 9Miettinen M,Kovatich AJ,Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions:A paraffin section analysis with diagnosis implications.Vichows Arch,1997,431:407-413.
  • 10Baloch ZW,Abraham S,Roberts S,et al. Differential expression of cytokeratins in follicular variant papillary carcinoma:an imunohistochemical study and its diagnostic utility. Hum Pathol,1999,30:1166-1171.

共引文献57

同被引文献70

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部